ABSTRACT Background Blood‐based biomarkers are increasingly used to identify Alzheimer's disease (AD) pathology and may play an important role in early disease screening and participant selection for clinical trials. However, their performance across stages of cognitive impairment remains unclear. This study examined w...
Maryam Abdolmaleki, Leslie S. Gaynor, Dan-Dan Liu et al.· Annals of Clinical and Trans...· 2 citations
Participation in ECHO programs was consistently associated with self-reported increases in provider knowledge of dementia diagnosis and management, greater perceived confidence in caring for older adults, and enhanced subjective communication and clinical skills.
Dominic Roby, K. Bhattacharyya, Ashish Joshi et al.· Journal of Applied Gerontolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.